Noxafil (Posaconazole)

Posaconazole, the active ingredient in Noxafil, the active ingredient in Noxafil, is a azole antifungal presented as an intravenous solution for infusion use. It treats invasive fungal infections such as aspergillosis and candidiasis in immunocompromised patients. GNH USA supplies Noxafil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

GNH USA supplies Noxafil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Posaconazole is an azole antifungal used to manage serious fungal infections in high‑risk patient groups.

- Invasive aspergillosis: Provides treatment and prevention of disease progression. - Invasive candidiasis: Helps eradicate Candida species from the bloodstream. - Prophylaxis in hematologic malignancy patients: Reduces incidence of fungal infections during chemotherapy. - Prophylaxis in stem‑cell transplant recipients: Lowers risk of invasive fungal disease post‑transplant.

Adverse reactions to intravenous posaconazole may vary in frequency and severity.

Common Side Effects: - Elevated ALT/AST liver enzymes - Nausea or vomiting - Diarrhea - Headache - Infusion‑related reactions such as flushing - Mild fever

Serious or Rare Side Effects: - Severe hepatic injury - Acute pancreatitis - Anaphylactic or severe hypersensitivity reactions - QT‑interval prolongation - Severe electrolyte disturbances - Renal impairment or failure

Posaconazole should be used with careful clinical monitoring and adherence to safety guidelines.

- Liver function monitoring: Check baseline and periodic liver enzymes. - Electrolyte assessment: Monitor potassium and magnesium levels. - Cardiac monitoring: Evaluate QT interval in patients with risk factors. - Drug‑interaction vigilance: Review concomitant medications for CYP3A4 substrates. - Pregnancy and lactation: Use only if clearly needed. - Store at ambient room temperature: keep in original packaging, protect from moisture.

Posaconazole has a notable interaction profile that requires assessment before co‑administration.

Major Interactions (Avoid): - Medications that > ? ? ");

Moderate ");

");

"""